4.6

CiteScore

2.2

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Volume 35 Issue 4
Jul.  2021
Turn off MathJax
Article Contents
Abstract
References
Related Articles
Wang Siwan, Jiang Hui, Wang Jia, Wu Haisi, Wu Ting, Ni Mengnan, Zhao Qianqian, Ji You, Zhang Ziting, Tang Chunming, Xu Huae. Superior in vitro anticancer effect of biomimetic paclitaxel and triptolide co-delivery system in gastric cancer[J]. The Journal of Biomedical Research, 2021, 35(4): 327-338. DOI: 10.7555/JBR.35.20210102
Citation: Wang Siwan, Jiang Hui, Wang Jia, Wu Haisi, Wu Ting, Ni Mengnan, Zhao Qianqian, Ji You, Zhang Ziting, Tang Chunming, Xu Huae. Superior in vitro anticancer effect of biomimetic paclitaxel and triptolide co-delivery system in gastric cancer[J]. The Journal of Biomedical Research, 2021, 35(4): 327-338. DOI: 10.7555/JBR.35.20210102
shu

Superior in vitro anticancer effect of biomimetic paclitaxel and triptolide co-delivery system in gastric cancer

  • 1.

    Department of Pharmaceutics, School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu 211166, China

  • 2.

    Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, Jiangsu 210009, China

  • 3.

    Department of Geriatric Gastroenterology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China

More Information
  • Corresponding author:

    Huae Xu and Chunming Tang, Department of Pharmaceutics, School of Pharmacy, Nanjing Medical University, 101 Longmian Avenue, Nanjing, Jiangsu 211166, China. E-mails: xuhuae@njmu.edu.cn and cmtang@njmu.edu.cn

  • Received Date: June 27, 2021
  • Revised Date: July 06, 2021
  • Accepted Date: July 11, 2021
  • Available Online: July 27, 2021
    Graphical Abstract
    • Abstract
  • As a well-known anticancer drug, paclitaxel (PTX), a first-line chemotherapeutic agent, remains unsatisfactory for gastric cancer therapy. It is reported that triptolide (TPL) could enhance the anti-gastric cancer effect of PTX. Considering the poor solubility of both drugs, we developed a red blood cell membrane-biomimetic nanosystem, an emerging tool in drug delivery, to co-load paclitaxel and triptolide (red blood cell membrane coated PTX and TPL co-loaded poly(lactic-co-glycolic acid) [PLGA] nanoparticles, RP(P/T)). The successful preparation was confirmed in terms of particle size, morphology, and surface markers assays. This biomimetic system could prolong circulation and escape immune surveillance. And these properties were verified by stability, in vitro drug release, and cellular uptake assays. Moreover, the MTT and colony formation assays demonstrated the superior anti-proliferation effect of the RP(P/T) to free drugs. The enhanced antitumor effects of RP(P/T) on migration and invasion were also evaluated by wound-healing and transwell assays. Overall, the bionic co-delivery nanoplatform with improved efficacy in vitro is a promising therapy for gastric cancer.
    • FullText(HTML)
    • References (29)
  • [1]
    Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394–424. doi: 10.3322/caac.21492
    [2]
    Chen W, Sun K, Zheng R, et al. Cancer incidence and mortality in China, 2014[J]. Chin J Cancer Res, 2018, 30(1): 1–12. doi: 10.21147/j.issn.1000-9604.2018.01.01
    [3]
    China-fact-sheets. The global cancer observatory[EB/OL]. [2020-11-25]. https://gco.iarc.fr/today/data/factsheets/populations/160-china-fact-sheets.pdf.
    [4]
    Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136: E359–386. doi: 10.1002/ijc.29210
    [5]
    NCCN guidelines for patients®: stomach cancer[EB/OL]. [2019-06-22]. https://www.nccn.org/patients/guidelines/content/PDF/stomach-patient.pdf.
    [6]
    Efferth T, Li PCH, Konkimalla VS, et al. From traditional Chinese medicine to rational cancer therapy[J]. Trends Mol Med, 2007, 13(8): 353–361. doi: 10.1016/j.molmed.2007.07.001
    [7]
    Wang W, Lin W, Wang Q, et al. The enhanced antitumor effect of combined triptolide and paclitaxel on pancreatic cancer cell lines[J]. J Clin Oncol, 2014, 32(S3): 335.
    [8]
    Li X, Lu X, Xu H, et al. Paclitaxel/tetrandrine coloaded nanoparticles effectively promote the apoptosis of gastric cancer cells based on "oxidation therapy"[J]. Mol Pharmaceut, 2012, 9(2): 222–229. doi: 10.1021/mp2002736
    [9]
    Li X, Yu N, Li J, et al. Novel "carrier-free" nanofiber codelivery systems with the synergistic antitumor effect of paclitaxel and tetrandrine through the enhancement of mitochondrial apoptosis[J]. ACS Appl Mater Interfaces, 2020, 12(9): 10096–10106. doi: 10.1021/acsami.9b17363
    [10]
    Chen S, Dai Y, Zhao J, et al. A mechanistic overview of triptolide and celastrol, natural products from Tripterygium wilfordii Hook F[J]. Front Pharmacol, 2018, 9: 104. doi: 10.3389/fphar.2018.00104
    [11]
    Roy V, LaPlant BR, Gross GG, et al. Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531)[J]. Ann Oncol, 2009, 20(3): 449–453. doi: 10.1093/annonc/mdn661
    [12]
    Couvreur P. Nanoparticles in drug delivery: past, present and future[J]. Adv Drug Deliv Rev, 2013, 65(1): 21–23. doi: 10.1016/j.addr.2012.04.010
    [13]
    Wang L, Jia E. Ovarian cancer targeted hyaluronic acid-based nanoparticle system for paclitaxel delivery to overcome drug resistance[J]. Drug Deliv, 2016, 23(5): 1810–1817. doi: 10.3109/10717544.2015.1101792
    [14]
    Ahmed F, Pakunlu RI, Brannan A, et al. Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug[J]. J Control Release, 2006, 116(2): 150–158. doi: 10.1016/j.jconrel.2006.07.012
    [15]
    Xu H, Lu X, Li J, et al. Superior antitumor effect of extremely high drug loading self-assembled paclitaxel nanofibers[J]. Int J Pharmaceut, 2017, 526(1-2): 217–224. doi: 10.1016/j.ijpharm.2017.04.081
    [16]
    Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery[J]. ACS Nano, 2009, 3(1): 16–20. doi: 10.1021/nn900002m
    [17]
    Patra JK, Das G, Fraceto LF, et al. Nano based drug delivery systems: recent developments and future prospects[J]. J Nanobiotechnol, 2018, 16(1): 71. doi: 10.1186/s12951-018-0392-8
    [18]
    Hu C, Zhang L, Aryal S, et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform[J]. Proc Natl Acad Sci USA, 2011, 108(27): 10980–10985. doi: 10.1073/pnas.1106634108
    [19]
    Kroll AV, Fang R, Zhang L. Biointerfacing and applications of cell membrane-coated nanoparticles[J]. Bioconjugate Chem, 2017, 28(1): 23–32. doi: 10.1021/acs.bioconjchem.6b00569
    [20]
    Fang R, Kroll AV, Gao W, et al. Cell membrane coating nanotechnology[J]. Adv Mater, 2018, 30(23): 1706759. doi: 10.1002/adma.201706759
    [21]
    Tang C, Wang C, Zhang Y, et al. Recognition, intervention, and monitoring of neutrophils in acute ischemic stroke[J]. Nano Lett, 2019, 19(7): 4470–4477. doi: 10.1021/acs.nanolett.9b01282
    [22]
    Hu Q, Sun W, Wang C, et al. Recent advances of cocktail chemotherapy by combination drug delivery systems[J]. Adv Drug Deliv Rev, 2016, 98: 19–34. doi: 10.1016/j.addr.2015.10.022
    [23]
    Oldenborg PA, Zheleznyak A, Fang YF, et al. Role of CD47 as a marker of self on red blood cells[J]. Science, 2000, 288(5473): 2051–2054. doi: 10.1126/science.288.5473.2051
    [24]
    Li W, Ng JMK, Wong C, et al. Molecular alterations of cancer cell and tumour microenvironment in metastatic gastric cancer[J]. Oncogene, 2018, 37(36): 4903–4920. doi: 10.1038/s41388-018-0341-x
    [25]
    Long Y, Lu Z, Mei L, et al. Enhanced melanoma-targeted therapy by "Fru-Blocked" phenyboronic acid-modified multiphase antimetastatic micellar nanoparticles[J]. Adv Sci, 2018, 5(11): 1800229. doi: 10.1002/advs.201800229
    [26]
    Zhao H, Yang Z, Wang X, et al. Triptolide inhibits ovarian cancer cell invasion by repression of matrix metalloproteinase 7 and 19 and upregulation of E-cadherin[J]. Exp Mol Med, 2012, 44(11): 633–641. doi: 10.3858/emm.2012.44.11.072
    [27]
    Sun B, Taha MS, Ramsey B, et al. Intraperitoneal chemotherapy of ovarian cancer by hydrogel depot of paclitaxel nanocrystals[J]. J Control Release, 2016, 235: 91–98. doi: 10.1016/j.jconrel.2016.05.056
    [28]
    Liu Y, Ng Y, Toh MR, et al. Lipid-dendrimer hybrid nanosystem as a novel delivery system for paclitaxel to treat ovarian cancer[J]. J Control Release, 2015, 220: 438–446. doi: 10.1016/j.jconrel.2015.11.004
    [29]
    Peng J, Chen J, Xie F, et al. Herceptin-conjugated paclitaxel loaded PCL-PEG worm-like nanocrystal micelles for the combinatorial treatment of HER2-positive breast cancer[J]. Biomaterials, 2019, 222: 119420. doi: 10.1016/j.biomaterials.2019.119420
    • Related Articles

  • Related Articles

    [1]Pavan Kumar Dhanyamraju, Trupti N. Patel. Melanoma therapeutics: a literature review[J]. The Journal of Biomedical Research, 2022, 36(2): 77-97. DOI: 10.7555/JBR.36.20210163
    [2]Yoon Su Young, Kim Si-Wook, Kim Dohun, Hong Jong-Myeon. Contained local compression on peri-ascending aortic area for postoperative bleeding control: a case report[J]. The Journal of Biomedical Research, 2021, 35(1): 72-74. DOI: 10.7555/JBR.34.20200085
    [3]Yang Lukun, Tautz Timothy, Zhang Shulin, Fomina Alla, Liu Hong. The current status of malignant hyperthermia[J]. The Journal of Biomedical Research, 2020, 34(2): 75-85. DOI: 10.7555/JBR.33.20180089
    [4]Didi Zhu, Jiamin Yuan, Rui Zhu, Yao Wang, Zhiyong Qian, Jiangang Zou. Pathway-based analysis of genome-wide association study of circadian phenotypes[J]. The Journal of Biomedical Research, 2018, 32(5): 361-370. DOI: 10.7555/JBR.32.20170102
    [5]Sang-Yong Eom, Dong-Hyuk Yim, Jung-Hyun Kim, Joo-Byung Chae, Yong-Dae Kim, Heon Kim. A pilot exome-wide association study of age-related cataract in Koreans[J]. The Journal of Biomedical Research, 2016, 30(3): 186-190. DOI: 10.7555/JBR.30.2016K0002
    [6]Shaoli Wang, Jingyun Zhang, Tao Sheng, Wei Lu, Dengshun Miao. Hippocampal ischemia causes deficits in local field potential and synaptic plasticity[J]. The Journal of Biomedical Research, 2015, 29(5): 370-379. DOI: 10.7555/JBR.29.20150010
    [7]Ping Zeng, Yang Zhao, Cheng Qian, Liwei Zhang, Ruyang Zhang, Jianwei Gou, Jin Liu, Liya Liu, Feng Chen. Statistical analysis for genome-wide association study[J]. The Journal of Biomedical Research, 2015, 29(4): 285-297. DOI: 10.7555/JBR.29.20140007
    [8]Chih-Kun Huang, Amit Garg, Hsin-Chih Kuao, Po-Chih Chang, Ming-Che Hsin. Bariatric surgery in old age: a comparative study of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy in an Asia centre of excellence[J]. The Journal of Biomedical Research, 2015, 29(2): 118-124. DOI: 10.7555/JBR.29.20140108
    [9]Yaomin Zhu, Guixia Jing, Wei Yuan. Preoperative administration of intramuscular dezocine reduces postoperative pain for laparoscopic cholecystectomy[J]. The Journal of Biomedical Research, 2011, 25(5): 356-361. DOI: 10.1016/S1674-8301(11)60047-X
    [10]Yangyang Zhang, Yanhu Wu, Biao Yuan, Xiang Liu, Sheng Zhao, Zhi Li, Yu Xia. Coronary artery bypass grafting with concomitant resection for carcinoma of lung[J]. The Journal of Biomedical Research, 2010, 24(1): 77-80.

  • Cited by

    Periodical cited type(6)

    1. Paolino G, Podo Brunetti A, De Rosa C, et al. Anorectal melanoma: systematic review of the current literature of an aggressive type of melanoma. Melanoma Res, 2024, 34(6): 487-496. DOI:10.1097/CMR.0000000000001003
    2. Illa SK, Mumtaz S, Nath S, et al. Characterization of runs of Homozygosity revealed genomic inbreeding and patterns of selection in indigenous sahiwal cattle. J Appl Genet, 2024, 65(1): 167-180. DOI:10.1007/s13353-023-00816-1
    3. Ugonabo O, Mohamed M, Ezeh E, et al. A Rare Metastatic Primary Rectal Melanoma in a Geriatric Male. J Med Cases, 2022, 13(8): 369-373. DOI:10.14740/jmc3929
    4. Si M, Cao X. Considering Computational Mathematics IGHG3 as Malignant Melanoma Is Associated with Immune Infiltration of Malignant Melanoma. Biomed Res Int, 2022, 2022: 4168937. DOI:10.1155/2022/4168937
    5. Nonaka K, Kudou K, Sasaki S, et al. Primary anorectal malignant melanoma with laparoscopic abdominoperineal resection: a case study and review of the relevant literature. Int Cancer Conf J, 2020, 9(3): 116-122. DOI:10.1007/s13691-020-00401-x
    6. Heo JR, Hwang KA, Kim SU, et al. A Potential Therapy Using Engineered Stem Cells Prevented Malignant Melanoma in Cellular and Xenograft Mouse Models. Cancer Res Treat, 2019, 51(2): 797-811. DOI:10.4143/crt.2018.364

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (1643) PDF downloads (147) Cited by(6)
    Related

    ©2023 by the Editorial Department of the Journals of Nanjing Medical University. All rights reserved.   苏ICP备05071376号-5

    Supported by: Beijing Renhe Information Technology Co., Ltd. E-mail: info@rhhz.net  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return